Eli Lilly & Company Foundation
Non-Profit
Active
Indianapolis, United States
15
49M
15
0.27
3
- Areas of investment
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 3
- Rounds per year
- 0.27
- Investments by industry
- Biotechnology (12)
- Therapeutics (5)
- Biopharma (3)
- Health Care (3)
- Medical (3) Show 6 more
- Investments by region
-
- United States (14)
- United Kingdom (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ajax Therapeutics | 13 May 2024 | Biotechnology, Medical, Life Science | Late Stage Venture | 95M | United States, Massachusetts, Cambridge |
| Fountain Therapeutics | 18 Nov 2021 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 15M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.